Results 301 to 310 of about 138,687 (371)

Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy Adherence

Journal of Acquired Immune Deficiency Syndromes, 2002
N. Press, M. Tyndall, E. Wood, R. Hogg, J. Montaner   +4 more
semanticscholar   +1 more source

The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time

Immunologic research, 2020
J. Quinn, J. Orange, V. Modell, F. Modell   +3 more
semanticscholar   +1 more source

Efficacy and Immunologic Responses to Influenza Vaccine in HIV-1-Infected Patients

Journal of Acquired Immune Deficiency Syndromes, 2005
H. Yamanaka, K. Teruya, Mari Tanaka, Y. Kikuchi, Takao Takahashi, S. Kimura, S. Oka   +6 more
semanticscholar   +1 more source

Unexplained post-acute infection syndromes

Nature Medicine, 2022
Jan Choutka, Mady Hornig, Akiko Iwasaki
exaly  

Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.

Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 1995
D. Henrard, Eric S. Daar, H. Farzadegan, S. J. Clark, Jack Phillips, George M. Shaw, Michael P. Busch   +6 more
semanticscholar   +1 more source

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes

Ca-A Cancer Journal for Clinicians, 2018
Patrick M Boland, Matthew B Yurgelun
exaly  

Genetics, genomics, and cancer risk assessment

Ca-A Cancer Journal for Clinicians, 2011
Kenneth Offit
exaly  

Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency

, 1976
M. D. Aronson
openalex   +1 more source

Immunology of Groups at Risk for Acquired Immune Deficiency Syndrome

2015
openaire   +3 more sources

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly